# § 522.1410   Methylprednisolone.

(a) *Specifications.* Each milliliter of suspension contains 20 or 40 milligrams (mg) of methylprednisolone acetate.


(b) *Sponsors.* See Nos. 054771 and 069043 in § 510.600(c) of this chapter. 


(c) [Reserved]


(d) *Conditions of use*—(1) *Dogs*—(i) *Amount.* Administer 2 to 40 mg (up to 120 mg in extremely large breeds or dogs with severe involvement) by intramuscular injection or up to 20 mg by intrasynovial injection.


(ii) *Indications for use.* For treatment of inflammation and related disorders; treatment of allergic and dermatologic disorders; and as supportive therapy to antibacterial treatment of severe infections.


(iii) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.


(2) *Cats*—(i) *Amount.* Administer 10 to 20 mg by intramuscular injection.


(ii) *Indications for use.* For treatment of inflammation and related disorders; treatment of allergic and dermatologic disorders; and as supportive therapy to antibacterial treatment of severe infections.


(iii) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.


(3) *Horses*—(i) *Amount.* Administer 200 mg by intramuscular injection or 40 to 240 mg by intrasynovial injection.


(ii) *Indications for use.* For treatment of inflammation and related disorders.


(iii) *Limitations.* Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.



---

[N] [43 FR 59058, Dec. 19, 1978, as amended at 51 FR 741, Jan. 8, 1986; 53 FR 40728, Oct. 18, 1988; 62 FR 35076, June 30, 1997; 76 FR 53051, Aug. 25, 2011; 78 FR 21060, Apr. 9, 2013; 79 FR 16191, Mar. 25, 2014; 83 FR 48946, Sept. 28, 2018] 




